{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T02:14:16Z","timestamp":1778984056458,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":2943,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Merck"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1093\/annonc\/mdr001","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T19:28:40Z","timestamp":1300217320000},"page":"2417-2423","source":"Crossref","is-referenced-by-count":47,"title":["Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study"],"prefix":"10.1016","volume":"22","author":[{"given":"J.E.","family":"Kurtz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.","family":"Kaminsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Floquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Veillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dorum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Elit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Petru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Scambia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Varsellona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pujade-Lauraine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr001_bb0010","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ygyno.2005.04.037","article-title":"Treatment patterns by decade of life in elderly women (\u2265 70 years of age) with ovarian cancer","volume":"98","author":"Uyar","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0015","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.2820710218","article-title":"Age as a prognostic factor in ovarian carcinoma","volume":"71","author":"Thigpen","year":"1993","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr001_bb0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/cncr.2820710223","article-title":"Age contrasts in patients with advanced epithelial ovarian cancer. The M.D. Anderson Cancer Center experience","volume":"71","author":"Gershenson","year":"1993","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr001_bb0025","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2005.08.029","article-title":"Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR)","volume":"100","author":"Wimberger","year":"2006","journal-title":"Arbeitsgemeinshaft. Gynecol Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0030","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1006\/gyno.2002.6759","article-title":"Age contrasts in clinical characteristics and patterns of care in patients with epithelial ovarian cancer","volume":"86","author":"Bruchim","year":"2002","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0035","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ygyno.2007.04.012","article-title":"Response and outcomes in elderly patients with stage IIIC\u2013IV ovarian cancer receiving platinum-taxane chemotherapy","volume":"106","author":"Eisenhauer","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0040","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/annonc\/mdl400","article-title":"Carboplatin\/cyclophosphamide or carboplatin\/paclitaxel in elderly patients with advanced ovarian cancer? Analysis of two consecutive trials from the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens","volume":"18","author":"Tr\u00e9dan","year":"2007","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdr001_bb0045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/annonc\/mdl401","article-title":"Feasibility, toxicity and quality of life of first-line chemotherapy with platinum\/paclitaxel in elderly patients aged >or= 70 years with advanced ovarian cancer\u2014a study by the AGO OVAR Germany","volume":"18","author":"Hilpert","year":"2007","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1093\/annonc\/mdr001_bb0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/annonc\/mdl483","article-title":"Is carboplatin\u2013paclitaxel combination the standard treatment of elderly ovarian cancer patients?","volume":"18","author":"Zola","year":"2007","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1093\/annonc\/mdr001_bb0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.critrevonc.2007.12.005","article-title":"A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian Cancer (MITO-5) study","volume":"66","author":"Pignata","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1093\/annonc\/mdr001_bb0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ygyno.2004.04.022","article-title":"Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer","volume":"94","author":"Hershman","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11864-009-0093-5","article-title":"Chemotherapy for ovarian cancer in the older adult","volume":"10","author":"Steer","year":"2009","journal-title":"Curr Treat Options Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0070","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.critrevonc.2008.12.010","article-title":"Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study","volume":"71","author":"Pignata","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1093\/annonc\/mdr001_bb0075","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/cncr.10385","article-title":"Performance status rather than age is the key prognostic factor in second-line treatment of elderly patients with epithelial ovarian carcinoma","volume":"94","author":"Gronlund","year":"2002","journal-title":"Cancer"},{"issue":"20","key":"10.1093\/annonc\/mdr001_bb0080","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1200\/JCO.2009.25.7519","article-title":"Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin for patients with platinum-sensitive ovarian cancer in late relapse","volume":"28","author":"Pujade-Lauraine","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/annonc\/mdl376","article-title":"Second-line chemotherapy with pegylated liposomal doxorubicin and carboplatin is highly effective in patients with advanced ovarian cancer in late relapse: a GINECO phase II trial","volume":"18","author":"Ferrero","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0090","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/annonc\/mdi368","article-title":"Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma","volume":"16","author":"Freyer","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr001_bb0095","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1159\/000231885","article-title":"Geriatric oncology: how far have we gone and what are the next steps?","volume":"77","author":"Kurtz","year":"2009","journal-title":"Oncology"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419377166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419377166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/22\/11\/2417\/527194\/mdr001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T19:55:35Z","timestamp":1625169335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419377166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0923753419377166"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr001","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}